Kangpu Biopharmaceuticals, a clinical-stage company based in Hefei, China, announced today that the Company has successfully ...

The challenge persists, but, with a renewed focus from regulatory bodies and trial sponsors alike on improving enrolment ...

SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") ...

How Canada’s clinical trial industry exploits test subjects, a drama-filled return to the Hill and a crowded byelection ...

A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical ...

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic ...

The Outsourcing in Clinical Trials New England conference will gather pharma experts to discuss the current clinical trial ...

The Alliance for Clinical Trials in Oncology today announced that final results will be presented at ESMO 2024 from CABINET ...

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary ...

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

The UNLV/GAP alliance intends to offer both brain health programs and scientific research opportunities, bolstering opportunities for Southern Nevadans clinically at risk for neurodegenerative ...